FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) Read more
US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab Read more
US FDA grants priority review to Roche’s Tecentriq as adjuvant treatment for non-small cell lung cancer Read more